Showing results (1-10 of 32) with videos related to
Sort By:
Pageof 4
Cancer Cell|November 9, 2021
T cell engagers in solid tumors kick the door downMaria de Miguel, Emiliano CalvoCancer Cell|August 5, 2020
Clinical Challenges of Immune Checkpoint InhibitorsMaria de Miguel, Emiliano CalvoMycological Research|November 11, 2005
A revision of the descriptions of ectomycorrhizas published since 1961Miriam De Roman, Vanessa Claveria, Ana Maria De MiguelCurrent Oncology Reports|February 26, 2022
New Checkpoint Inhibitors on the Road: Targeting TIM-3 in Solid TumorsAna Luiza Gomes de Morais, Sara Cerdá, Maria de MiguelCurrent Opinion in Pharmacology|June 21, 2021
Adoptive cell therapy for solid tumors: Chimeric antigen receptor T cells and beyondVictor Moreno, Tatiana Hernandez, Maria de Miguel, et al.Journal of Nephrology|July 2, 2003
Non-heart-beating donors: experience from the Hospital Clinico of MadridAna Isabel Sanchez-Fructuoso, Maria de Miguel Marques, Dolores Prats, et al.Cancer Treatment Reviews|November 6, 2020
Comparison of radiological criteria for hyperprogressive disease in response to immunotherapyAna Luiza Gomes da Morais, Maria de Miguel, José Miguel Cardenas, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 21, 2020
T-cell-engaging Therapy for Solid TumorsMaria de Miguel, Pablo Umana, Ana Luiza Gomes de Morais, et al.Cancer|June 20, 2020
Increased vulnerability of clinical research units during the COVID-19 crisis and their protectionMaria de Miguel, Bernard Doger, Valentina Boni, et al.Cancer Treatment Reviews|January 28, 2024
The state of the art of EGFR exon 20 insertions in non-small cell lung cancer: Diagnosis and future perspectivesMiriam Dorta-Suárez, Maria de Miguel, Oscar Amor-Carro, et al.Pageof 4